Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan
Mad in America
OCTOBER 18, 2023
Dhar: Is this what inspired you to create the “documentary” for ‘Motivational Deficiency Disorder’ and the April Fool piece in BMJ along with it? In 2022, drug and device makers paid 20 billion Australian dollars to U.S. We investigated social anxiety disorder. What was that about? Moynihan: That’s exactly right.
Let's personalize your content